Albumin modulates S1P delivery from red blood cells in perfused microvessels: Mechanism of the protein effect

R. H. Adamson, J. F. Clark, M. Radeva, A. Kheirolomoom, K. W. Ferrara, F. E. Curry

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Removal of plasma proteins from perfusates increases vascular permeability. The common interpretation of the action of albumin is that it forms part of the permeability barrier by electrostatic binding to the endothelial glycocalyx. We tested the alternate hypothesis that removal of perfusate albumin in rat venular microvessels decreased the availability of sphingosine-1-phosphate (S1P), which is normally carried in plasma bound to albumin and lipoproteins and is required to maintain stable baseline endothelial barriers (Am J Physiol Heart Circ Physiol 303: H825-H834, 2012). Red blood cells (RBCs) are a primary source of S1P in the normal circulation. We compared apparent albumin permeability coefficients [solute permeability (Ps)] measured using perfusates containing albumin (10 mg/ml, control) and conditioned by 20-min exposure to rat RBCs with Ps when test perfusates were in RBC-conditioned protein-free Ringer solution. The control perfusate S1P concentration (439 ± 46 nM) was near the normal plasma value at 37°C and established a stable baseline Ps (0.9 ± 0.4 × 10-6 cm/s). Ringer solution perfusate contained 52 ± 8 nM S1P and increased Ps more than 10-fold (16.1 ± 3.9 × 10-6 cm/s). Consistent with albumin-dependent transport of S1P from RBCs, S1P concentrations in RBC-conditioned solutions decreased as albumin concentration, hematocrit, and temperature decreased. Protein-free Ringer solution perfusates that used liposomes instead of RBCs as flow markers failed to maintain normal permeability, reproducing the "albumin effect" in these mammalian microvessels. We conclude that the albumin effect depends on the action of albumin to facilitate the release and transport of S1P from RBCs that normally provide a significant amount of S1P to the endothelium.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume306
Issue number7
DOIs
StatePublished - Apr 1 2014

Fingerprint

Microvessels
Albumins
Erythrocytes
Proteins
Permeability
sphingosine 1-phosphate
Glycocalyx
Capillary Permeability
Static Electricity
Hematocrit
Liposomes
Lipoproteins
Endothelium
Blood Proteins
Reference Values
Temperature

Keywords

  • Albumin
  • Endothelium
  • Permeability
  • Sphingosine-1-phosphate
  • Vascular

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Albumin modulates S1P delivery from red blood cells in perfused microvessels : Mechanism of the protein effect. / Adamson, R. H.; Clark, J. F.; Radeva, M.; Kheirolomoom, A.; Ferrara, K. W.; Curry, F. E.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 306, No. 7, 01.04.2014.

Research output: Contribution to journalArticle

Adamson, R. H. ; Clark, J. F. ; Radeva, M. ; Kheirolomoom, A. ; Ferrara, K. W. ; Curry, F. E. / Albumin modulates S1P delivery from red blood cells in perfused microvessels : Mechanism of the protein effect. In: American Journal of Physiology - Heart and Circulatory Physiology. 2014 ; Vol. 306, No. 7.
@article{0c2192e0211a4574adc4936ee7f5e46e,
title = "Albumin modulates S1P delivery from red blood cells in perfused microvessels: Mechanism of the protein effect",
abstract = "Removal of plasma proteins from perfusates increases vascular permeability. The common interpretation of the action of albumin is that it forms part of the permeability barrier by electrostatic binding to the endothelial glycocalyx. We tested the alternate hypothesis that removal of perfusate albumin in rat venular microvessels decreased the availability of sphingosine-1-phosphate (S1P), which is normally carried in plasma bound to albumin and lipoproteins and is required to maintain stable baseline endothelial barriers (Am J Physiol Heart Circ Physiol 303: H825-H834, 2012). Red blood cells (RBCs) are a primary source of S1P in the normal circulation. We compared apparent albumin permeability coefficients [solute permeability (Ps)] measured using perfusates containing albumin (10 mg/ml, control) and conditioned by 20-min exposure to rat RBCs with Ps when test perfusates were in RBC-conditioned protein-free Ringer solution. The control perfusate S1P concentration (439 ± 46 nM) was near the normal plasma value at 37°C and established a stable baseline Ps (0.9 ± 0.4 × 10-6 cm/s). Ringer solution perfusate contained 52 ± 8 nM S1P and increased Ps more than 10-fold (16.1 ± 3.9 × 10-6 cm/s). Consistent with albumin-dependent transport of S1P from RBCs, S1P concentrations in RBC-conditioned solutions decreased as albumin concentration, hematocrit, and temperature decreased. Protein-free Ringer solution perfusates that used liposomes instead of RBCs as flow markers failed to maintain normal permeability, reproducing the {"}albumin effect{"} in these mammalian microvessels. We conclude that the albumin effect depends on the action of albumin to facilitate the release and transport of S1P from RBCs that normally provide a significant amount of S1P to the endothelium.",
keywords = "Albumin, Endothelium, Permeability, Sphingosine-1-phosphate, Vascular",
author = "Adamson, {R. H.} and Clark, {J. F.} and M. Radeva and A. Kheirolomoom and Ferrara, {K. W.} and Curry, {F. E.}",
year = "2014",
month = "4",
day = "1",
doi = "10.1152/ajpheart.00829.2013",
language = "English (US)",
volume = "306",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "7",

}

TY - JOUR

T1 - Albumin modulates S1P delivery from red blood cells in perfused microvessels

T2 - Mechanism of the protein effect

AU - Adamson, R. H.

AU - Clark, J. F.

AU - Radeva, M.

AU - Kheirolomoom, A.

AU - Ferrara, K. W.

AU - Curry, F. E.

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Removal of plasma proteins from perfusates increases vascular permeability. The common interpretation of the action of albumin is that it forms part of the permeability barrier by electrostatic binding to the endothelial glycocalyx. We tested the alternate hypothesis that removal of perfusate albumin in rat venular microvessels decreased the availability of sphingosine-1-phosphate (S1P), which is normally carried in plasma bound to albumin and lipoproteins and is required to maintain stable baseline endothelial barriers (Am J Physiol Heart Circ Physiol 303: H825-H834, 2012). Red blood cells (RBCs) are a primary source of S1P in the normal circulation. We compared apparent albumin permeability coefficients [solute permeability (Ps)] measured using perfusates containing albumin (10 mg/ml, control) and conditioned by 20-min exposure to rat RBCs with Ps when test perfusates were in RBC-conditioned protein-free Ringer solution. The control perfusate S1P concentration (439 ± 46 nM) was near the normal plasma value at 37°C and established a stable baseline Ps (0.9 ± 0.4 × 10-6 cm/s). Ringer solution perfusate contained 52 ± 8 nM S1P and increased Ps more than 10-fold (16.1 ± 3.9 × 10-6 cm/s). Consistent with albumin-dependent transport of S1P from RBCs, S1P concentrations in RBC-conditioned solutions decreased as albumin concentration, hematocrit, and temperature decreased. Protein-free Ringer solution perfusates that used liposomes instead of RBCs as flow markers failed to maintain normal permeability, reproducing the "albumin effect" in these mammalian microvessels. We conclude that the albumin effect depends on the action of albumin to facilitate the release and transport of S1P from RBCs that normally provide a significant amount of S1P to the endothelium.

AB - Removal of plasma proteins from perfusates increases vascular permeability. The common interpretation of the action of albumin is that it forms part of the permeability barrier by electrostatic binding to the endothelial glycocalyx. We tested the alternate hypothesis that removal of perfusate albumin in rat venular microvessels decreased the availability of sphingosine-1-phosphate (S1P), which is normally carried in plasma bound to albumin and lipoproteins and is required to maintain stable baseline endothelial barriers (Am J Physiol Heart Circ Physiol 303: H825-H834, 2012). Red blood cells (RBCs) are a primary source of S1P in the normal circulation. We compared apparent albumin permeability coefficients [solute permeability (Ps)] measured using perfusates containing albumin (10 mg/ml, control) and conditioned by 20-min exposure to rat RBCs with Ps when test perfusates were in RBC-conditioned protein-free Ringer solution. The control perfusate S1P concentration (439 ± 46 nM) was near the normal plasma value at 37°C and established a stable baseline Ps (0.9 ± 0.4 × 10-6 cm/s). Ringer solution perfusate contained 52 ± 8 nM S1P and increased Ps more than 10-fold (16.1 ± 3.9 × 10-6 cm/s). Consistent with albumin-dependent transport of S1P from RBCs, S1P concentrations in RBC-conditioned solutions decreased as albumin concentration, hematocrit, and temperature decreased. Protein-free Ringer solution perfusates that used liposomes instead of RBCs as flow markers failed to maintain normal permeability, reproducing the "albumin effect" in these mammalian microvessels. We conclude that the albumin effect depends on the action of albumin to facilitate the release and transport of S1P from RBCs that normally provide a significant amount of S1P to the endothelium.

KW - Albumin

KW - Endothelium

KW - Permeability

KW - Sphingosine-1-phosphate

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=84900544251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900544251&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00829.2013

DO - 10.1152/ajpheart.00829.2013

M3 - Article

C2 - 24531813

AN - SCOPUS:84900544251

VL - 306

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 7

ER -